Decreased CalDAG-GEF1/Rap1 signaling, as in cases of genetic deletion of RASGRP2 in mice [100] or loss of function mutations in humans [107,108], has been suggested as a cause of the rare leukocyte adhesion deficiency type III (LAD-III). This evidence concerns the gene RAP1A and Leukocyte adhesion deficiency type III.